Health·STATSTAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammationNovo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, another blow for the approach.Center7h agoRead at STAT→
STAT·20h agoSTAT+: Not so fast: Diabetes association panel not done reviewing ejections from its June meeting
STAT·3d agoSTAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies
2 sourcesNPRLean L·10h agoThe copper peptide trend has gone from creams to injections — ahead of the science
STAT·3d agoSTAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more
STAT·3d agoOpinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains